Research Participation With Transgender and Gender-Diverse Youth
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Jun 21, 2023
Trial Information
Current as of November 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding why transgender and gender-diverse youth choose to participate in research studies. Historically, these individuals have often been left out of research, and this study aims to gather insights that could help improve their representation in future research. By learning more about their experiences and decision-making, the researchers hope to make it easier for transgender and gender-diverse youth to take part in studies that matter to them.
To be eligible for this study, participants need to be aged between 15 and 21 years old and identify as a gender different from the sex they were assigned at birth. Those who are younger than 15 or older than 21, as well as those whose gender identity matches their sex assigned at birth, cannot participate. If eligible, participants will share their thoughts and experiences, contributing to a better understanding of how to make research more inclusive for transgender and gender-diverse youth. This is an important step towards ensuring that their voices are heard in research that impacts their lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Gender identity different then sex assigned at birth
- • Between the ages 15-21 years
- Exclusion Criteria:
- • Gender identity the same as their sex assigned at birth
- • Younger than 15 years of age, and older than 21 years of age
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Trial Officials
An Pham, MD
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported